Your browser doesn't support javascript.
loading
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.
Nghiemphu, Phioanh Leia; Ebiana, Victoria Asuquo; Wen, Patrick; Gilbert, Mark; Abrey, Lauren E; Lieberman, F; DeAngelis, Lisa M; Robins, H Ian; Yung, W K Alfred; Chang, Susan; Drappatz, Jan; Mehta, Minesh P; Levin, Victor A; Aldape, Kenneth; Dancey, Janet E; Wright, J J; Prados, Michael; Kuhn, John; Cloughesy, Timothy F.
Afiliación
  • Nghiemphu PL; Department of Neurology, University of California, Los Angeles, 710 Westwood Plaza, Reed 1-230, Los Angeles, CA, 90230, USA. leian@ucla.edu.
  • Ebiana VA; Department of Neurology, University of California, Los Angeles, 710 Westwood Plaza, Reed 1-230, Los Angeles, CA, 90230, USA.
  • Wen P; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Gilbert M; Dana Farber Cancer Institute, Boston, MA, USA.
  • Abrey LE; Neuro-Oncology Branch National Cancer Institute, Bethesda, MD, USA.
  • Lieberman F; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • DeAngelis LM; University of Pittsburgh, Pittsburgh, PA, USA.
  • Robins HI; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yung WKA; University of Wisconsin, Madison, WI, USA.
  • Chang S; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Drappatz J; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA.
  • Mehta MP; University of Pittsburgh, Pittsburgh, PA, USA.
  • Levin VA; Baptist Health South Florida, Coral Gables, FL, USA.
  • Aldape K; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Dancey JE; University Health Ontario, Toronto, ON, Canada.
  • Wright JJ; National Cancer Institute Cancer Therapy Evaluation Program, Investigational Branch, Toronto, ON, Canada.
  • Prados M; Neuro-Oncology Branch National Cancer Institute, Bethesda, MD, USA.
  • Kuhn J; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, USA.
  • Cloughesy TF; The University of Texas College of Pharmacy, Austin, TX, USA.
J Neurooncol ; 136(1): 79-86, 2018 Jan.
Article en En | MEDLINE | ID: mdl-28988377
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma / Quinolonas / Sorafenib / Recurrencia Local de Neoplasia / Antineoplásicos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma / Quinolonas / Sorafenib / Recurrencia Local de Neoplasia / Antineoplásicos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos